Multi-national pharma is optimized for late-stage clinical research and international marketing. As a result, discovery has become the limiting factor in productivity. The industry needs a business model, a road map, that would enable it to operate effectively in the entrepreneurial community.
How To Fix Pharma’s Innovation Crisis (Part 2)
